Week six Flashcards
Nervous System Agents
A wide variety of both natural and artificial chemicals capable of altering information processing and signaling mechanisms within and among neurons
NSA effects are typically dose-dependent (i.e., effects vary with the amount of the agent administered (aka dose level)*
Some NSAs can cause reversible changes to neural function (e.g., alcohol, chlorpromazine) being diluted via metabolic action
Some NSAs can cause permanent changes to neural function (e.g., botulinum toxin, MPTP) through damaging action to neural tissue
Some NSAs can act as a “neuroprotectant” – resulting in the recovery or regeneration of affected neuron function
* There are a variety of dose-dependent relationships, including controversial ones, such as hormesis
PSYCHOPHARMACOLOGY
Study that utilizes knowledge and skill from chemistry and neuroscience.
Neurotoxicity
Most nervous system agents are neurotoxic at some dose level
Behavioural toxicology: subdiscipline of psychopharmacology that studies the effects of toxic levels of NS Agents on behaviour, cognition, emotion and consciousness…
MedWatch: USFDA medical product safety reporting program for health professionals, patients and consumers…
Characterizing Drug Action: Pharmacodynamics and Pharmacokinetics
Pharmacodynamics: Nervous System Agents have different effects and mechanisms of action upon nervous tissue sites depending on
the route of delivery,
the amount taken (the dose, purity, etc.),
the time-course of NS Agent action and movement throughout the body (affected by metabolism, etc.) – called the drug’s pharmacokinetics…
Effects of Nervous System Agents
Therapeutic Effects – the intended consequences on the NS of a nervous system agent (aka a drug ‘treatment’)
Side Effects – Effects that occur but are not related to the purpose of taking the drug
Contraindications – negative side effects
Placebo effects – Therapeutic effects not attributable to drug action (tends to work best on subjective symptoms such as pain)
The Dose Response
The functional relationship between the drug dose level & some dependent measure of drug’s effect
Dose Response Descriptors:
Median Effective Dose (e.g., ED50) the minimum dose level that produces a measurable therapeutic effect in 50% of the study sample
The Dose Response
Median Toxic dose (e.g., TD50) the minimum dose level that produces a measurable toxicity effect in 50% of the study sample
The Dose Response
Median Lethal dose (e.g., LD50), the minimum dose level that kills 50% of the study sample
Operational Definitions of Dose Response
“Subjective” Effects:
Experiential changes reported by patient (e.g., changes in attention, mood, perception, etc.)
Operational Definitions of Dose Response
Behavioural Effects:
Changes in patient’s behaviour (indicating effects on memory, decision making, communication, reaction time, fine motor coordination, speech, etc.)
Operational Definitions of Dose Response
Physiological Effects:
Changes to vegetative physiologic functions such as breathing rate, heart rate, body temperature, appetite, tremor, sleep levels, etc.
The Dose Response Curve
Typically represented as a curve on an x-y plot with dose on the x-axis and the dependent measure (normalized response) on the y axis
The shape of the curve is sigmoidal…
ED50 (aka median Effective Dose) = the lowest dose that proves effective for 50% of the participants in the study sample
An Example of an Experimental Dose-Response Measure:
Prepulse Inhibition of the Acoustic Startle Response
An unpredictable, brief (but LOUD) white noise burst presented through headphones typically elicits a strong acoustic startle response (including, among other things, an eye blink). The eye blink’s latency and amplitude can be quantified by measuring the electrical activity oftheorbicularis oculimuscle on the face with electrodes (see right eye, below).
Prepulse Inhibition Deficit
A deficit of prepulse inhibition occurs when the presence of the prepulse fails to reduce the magnitude of the acoustic startle response to the subsequent LOUD noise burst.
Prepulse inhibition deficit has been observed in patients with diagnoses related to abnormalities of automatic sensorimotor gating associated with early attentional mechanisms in the brain (e.g., in patients diagnosed with ADHD or schizophrenia).
Prepulse Inhibition: An Example of an Experimental Dose-Response Measure:
Drugs developed to treat attentional deficits might, therefore, be expected to restore the prepulse inhibition of the acoustic startle response to ‘typical’ levels at some (aka “effective”) drug dosage (e.g. taken as ED50 in a study sample).
Mechanisms of CNS Agent Action: Agonists and Antagonists.
There are two general ways that nervous system agents have an effect on neural communication
Agonists: increase efficiency of within or between neural signaling
Mechanisms of CNS Agent Action: Agonists and Antagonists
There are two general ways that nervous system agents have an effect on neural communication
Antagonists: decrease the efficiency of within or between neural signaling
AGONISTS
Two types:
Direct-acting agonists: NS Agents that directly bind to the membrane channels or postsynaptic receptors. Examples of direct-binding agonist drugs include dopamine, apomorphine, and nicotine.
Indirect-acting agonists: agonists that enhance the neurotransmitter actions by stimulating neurotransmitters’ release E.g. cocaine.
ANTAGONISTS
Two types:
Direct-acting Antagonist – block cell membrane ion channels or block NT from binding to the postsynaptic receptors.
A common example of a drug belonging to this category is Atropine.
Indirect-acting Antagonist – inhibit release or production of NT
An example of this type of drug is Reserpine.
NS Agents Can Affect Signaling Within Neurons: Channel blockers
are antagonistic NS Agents that reduce the flow of ions across the cell membrane, affecting the dynamics of the membrane potential of cells, including neurons.
There are specific channel blockers for all major ions affecting signaling within neurons (Na+,K+,Cl- and Ca++)
Natural agents
(E.g., Tetrodotoxin, found in various organs of the puffer fish*) is a Na+ channel blocker that completely inhibits the creation of action potentials by binding to the voltage-gated channels on axon membranes (recall the voltage-gated Na+ channels form the rising phase of the action potential)
Pharmaceutical channel blockers
act by inhibiting ion movement through neuron membranes (dependent on dose), altering the rate of depolarization, reducing neuron ‘excitability’ and action potential conduction velocity. E.g., Lidocain (a local anesthetic), Phenytoin and Oxcarbazepine (anticonvulsants) .
Channel openers (aka channel activators)
are agonistic NS Agents that facilitate the flow of ions across the cell membrane, affecting the dynamics of the membrane potential of cells, including neurons.
There are specific channel openers for all major ions affecting signaling within neurons (Na+,K+,Cl- and Ca++)